Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection

JAMA. 2021 Dec 28;326(24):2524-2526. doi: 10.1001/jama.2021.19996.

Abstract

This study examines antibody durability in individuals who received an mRNA SARS-CoV-2 vaccine with prior SARS-CoV-2 infection vs those without infection.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • COVID-19 / diagnosis
  • COVID-19 / immunology*
  • COVID-19 Nucleic Acid Testing
  • COVID-19 Vaccines / administration & dosage
  • COVID-19 Vaccines / immunology*
  • Confidence Intervals
  • Female
  • Health Personnel
  • Humans
  • Immunization, Secondary
  • Immunoglobulin G / blood*
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Spike Glycoprotein, Coronavirus / immunology*
  • Time Factors

Substances

  • COVID-19 Vaccines
  • Immunoglobulin G
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2